Format

Send to

Choose Destination
J Pediatr Hematol Oncol. 2015 Apr;37(3):e162-9. doi: 10.1097/MPH.0000000000000307.

Guidelines for the Standard Monitoring of Patients With Thalassemia: Report of the Thalassemia Longitudinal Cohort.

Author information

1
*Boston Children's Hospital, Boston, MA †Children's Hospital & Research Center Oakland, Oakland, CA ‡Weill Medical College of Cornell, New York, NY §Children's Memorial Hospital, Chicago, IL ∥University of Texas Southwestern Medical Center, Dallas, TX ¶Children's Hospital of Philadelphia, Philadelphia, PA.

Abstract

Chronic transfusion therapy has played a central role in extending life expectancy for patients with hemoglobinopathies such as thalassemia. However, this life-saving therapy is associated with numerous complications that now comprise the bulk of management considerations for patients with thalassemia. This review reports on the experience of the Thalassemia Longitudinal Cohort and reviews available literature to establish guidelines for the management of patients with thalassemia.

PMID:
26201037
PMCID:
PMC4511957
DOI:
10.1097/MPH.0000000000000307
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center